Susquehanna International Group’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $763K | Buy |
91,084
+75,460
| +483% | +$793K | ﹤0.01% | 8595 |
|
|
2025
Q4 | $225K | Sell |
15,624
-75,684
| -83% | -$943K | ﹤0.01% | 10613 |
|
|
2025
Q3 | $881K | Sell |
91,308
-61,352
| -40% | -$543K | ﹤0.01% | 7640 |
|
|
2025
Q2 | $1.25M | Buy |
152,660
+12,190
| +9% | +$102K | ﹤0.01% | 6866 |
|
|
2025
Q1 | $1M | Buy |
140,470
+31,666
| +29% | +$236K | ﹤0.01% | 7251 |
|
|
2024
Q4 | $841K | Buy |
108,804
+53,417
| +96% | +$502K | ﹤0.01% | 7398 |
|
|
2024
Q3 | $581K | Buy |
55,387
+30,382
| +122% | +$370K | ﹤0.01% | 8106 |
|
|
2024
Q2 | $293K | Buy |
25,005
+8,376
| +50% | +$130K | ﹤0.01% | 9500 |
|
|
2024
Q1 | $350K | Sell |
16,629
-3,399
| -17% | -$60.5K | ﹤0.01% | 9343 |
|
|
2023
Q4 | $360K | Sell |
20,028
-6,613
| -25% | -$116K | ﹤0.01% | 9439 |
|
|
2023
Q3 | $439K | Buy |
26,641
+9,679
| +57% | +$175K | ﹤0.01% | 8540 |
|
|
2023
Q2 | $339K | Sell |
16,962
-37,239
| -69% | -$717K | ﹤0.01% | 9188 |
|
|
2023
Q1 | $1.02M | Buy |
54,201
+39,050
| +258% | +$864K | ﹤0.01% | 6746 |
|
|
2022
Q4 | $344K | Sell |
15,151
-34,762
| -70% | -$786K | ﹤0.01% | 8768 |
|
|
2022
Q3 | $1.32M | Buy |
+49,913
| New | +$1.48M | ﹤0.01% | 5915 |
|
|
2022
Q2 | – | Sell |
-31,382
| Closed | -$784K | – | 13780 |
|
|
2022
Q1 | $1.04M | Sell |
31,382
-11,125
| -26% | -$309K | ﹤0.01% | 7007 |
|
|
2021
Q4 | $1.39M | Sell |
42,507
-91
| -0.2% | -$3.1K | ﹤0.01% | 6407 |
|
|
2021
Q3 | $1.78M | Buy |
42,598
+18,726
| +78% | +$674K | ﹤0.01% | 6086 |
|
|
2021
Q2 | $927K | Buy |
23,872
+5,828
| +32% | +$208K | ﹤0.01% | 7972 |
|
|
2021
Q1 | $615K | Buy |
18,044
+8,457
| +88% | +$361K | ﹤0.01% | 8997 |
|
|
2020
Q4 | $435K | Sell |
9,587
-13,042
| -58% | -$456K | ﹤0.01% | 8572 |
|
|
2020
Q3 | $623K | Buy |
22,629
+301
| +1% | +$9.81K | ﹤0.01% | 7218 |
|
|
2020
Q2 | $822K | Sell |
22,328
-14,002
| -39% | -$522K | ﹤0.01% | 6332 |
|
|
2020
Q1 | $1.18M | Sell |
36,330
-27,364
| -43% | -$1.14M | ﹤0.01% | 5029 |
|
|
2019
Q4 | $2.61M | Sell |
63,694
-49,245
| -44% | -$1.95M | ﹤0.01% | 3907 |
|
|
2019
Q3 | $4.02M | Buy |
112,939
+34,747
| +44% | +$1.41M | ﹤0.01% | 3030 |
|
|
2019
Q2 | $4.02M | Buy |
78,192
+58,716
| +301% | +$2.93M | ﹤0.01% | 3017 |
|
|
2019
Q1 | $1.12M | Sell |
19,476
-2,150
| -10% | -$107K | ﹤0.01% | 4837 |
|
|
2018
Q4 | $907K | Buy |
+21,626
| New | +$1.27M | ﹤0.01% | 4867 |
|
|
2018
Q2 | – | Sell |
-20,885
| Closed | -$997K | – | 10263 |
|
|
2018
Q1 | $623K | Sell |
20,885
-61,437
| -75% | -$1.79M | ﹤0.01% | 6198 |
|
|
2017
Q4 | $2.74M | Buy |
+82,322
| New | +$2.48M | ﹤0.01% | 3383 |
|
|
2017
Q1 | – | Sell |
-44,834
| Closed | -$832K | – | 9778 |
|
|
2016
Q4 | $832K | Buy |
+44,834
| New | +$857K | ﹤0.01% | 5914 |
|
|
2016
Q3 | – | Sell |
-12,404
| Closed | -$99K | – | 8921 |
|
|
2016
Q2 | $99K | Buy |
+12,404
| New | +$138K | ﹤0.01% | 8022 |
|
Other funds holding RGNX
RG
VCM
IHAM
Susquehanna International Group's RGNX Position: Q1 2026 in Review
Susquehanna International Group increased its Regenxbio (RGNX) stake by 483% in Q1 2026, buying an estimated $793K and bringing the position to 91,084 shares worth $763K. The position accounts for ﹤0.01% of the portfolio, ranked #8595.
Susquehanna International Group first reported a position in RGNX in Q2 2016 and has held it in 33 quarters since. The position peaked at $4.02M in Q3 2019. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.
- Susquehanna International Group held 91,084 shares of Regenxbio worth $763K as of Q1 2026.
- Susquehanna International Group bought 75,460 Regenxbio shares in Q1 2026, an estimated $793K.
- Regenxbio made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8595 holding.
- Susquehanna International Group first reported a position in Regenxbio in Q2 2016 and has held it in 33 quarters since.
- Susquehanna International Group's Regenxbio position peaked at $4.02M in Q3 2019.
- 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.